Lista de obras - Stephen F Madden - Dominio Público Uruguay

5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer.

artículo científico publicado en 2011

A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib

artículo científico publicado en 2017

ADAM10: a new player in breast cancer progression?

artículo científico publicado en 2015

Bidirectional KCNQ1:β-catenin interaction drives colorectal cancer cell differentiation

artículo científico publicado en 2017

BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome

artículo científico publicado en 2013

Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression

artículo científico publicado en 2015

Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.

artículo científico publicado en 2015

Detecting microRNA activity from gene expression data

artículo científico publicado en 2010

Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers.

artículo científico publicado en 2018

Digital extractor: analysis of digital differential display output.

artículo científico publicado en 2003

Distinct patterns in the regulation and evolution of human cancer genes

article

Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells.

artículo científico publicado en 2017

Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours

artículo científico publicado en 2012

Expression of anaesthetic and analgesic drug target genes in excised breast tumour tissue: Association with clinical disease recurrence or metastasis

artículo científico publicado en 2017

Gene expression analysis in prostate cancer: the importance of the endogenous control.

artículo científico publicado en 2012

Gene expression changes as markers of early lapatinib response in a panel of breast cancer cell lines

artículo científico publicado en 2012

Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression.

artículo científico publicado en 2004

Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung

artículo científico publicado en 2008

Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?

artículo científico publicado en 2013

Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.

artículo científico publicado en 2017

Increase in sialylation and branching in the mouse serum N-glycome correlates with inflammation and ovarian tumour progression

artículo científico publicado en 2013

Integrating transcription factor binding site information with gene expression datasets

artículo científico publicado en 2006

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

artículo científico publicado en 2011

Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007.

artículo científico publicado en 2017

Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors

artículo científico publicado en 2014

OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.

artículo científico publicado en 2014

Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.

artículo científico publicado en 2015

Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells

artículo científico publicado en 2016

Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology.

artículo científico publicado en 2002

Sustained Expression of Steroid Receptor Coactivator SRC-2/TIF-2 is Associated with Better Prognosis in Malignant Pleural Mesothelioma ⬇️

artículo científico publicado el 1 de enero de 2012

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer

artículo científico publicado en 2013

TGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation

artículo científico publicado en 2013

The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer

artículo científico publicado en 2016

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation

artículo científico publicado en 2017

Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer

artículo científico publicado en 2017

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.

artículo científico publicado en 2017

Vitamin D receptor as a target for breast cancer therapy

artículo científico

miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro

artículo científico publicado en 2012

Lista de obras de Stephen F Madden

5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer.

A preclinical evaluation of the MEK inhibitor refametinib in HER2-positive breast cancer cell lines including those with acquired resistance to trastuzumab or lapatinib

ADAM10: a new player in breast cancer progression?

Bidirectional KCNQ1:β-catenin interaction drives colorectal cancer cell differentiation

BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome

Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression

Delineating transcriptional networks of prognostic gene signatures refines treatment recommendations for lymph node-negative breast cancer patients.

Detecting microRNA activity from gene expression data

Development of a personalized therapeutic strategy for ERBB-gene-mutated cancers.

Digital extractor: analysis of digital differential display output.

Distinct patterns in the regulation and evolution of human cancer genes

Dual inhibition of IGF1R and ER enhances response to trastuzumab in HER2 positive breast cancer cells.

Evaluation of IGF1R and phosphorylated IGF1R as targets in HER2-positive breast cancer cell lines and tumours

Expression of anaesthetic and analgesic drug target genes in excised breast tumour tissue: Association with clinical disease recurrence or metastasis

Gene expression analysis in prostate cancer: the importance of the endogenous control.

Gene expression changes as markers of early lapatinib response in a panel of breast cancer cell lines

Gene expression fingerprints in human tubulointerstitial inflammation and fibrosis as prognostic markers of disease progression.

Hypoxia selectively activates the CREB family of transcription factors in the in vivo lung

Identification of transcription factors associated with castration-resistance: is the serum responsive factor a potential therapeutic target?

Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies.

Increase in sialylation and branching in the mouse serum N-glycome correlates with inflammation and ovarian tumour progression

Integrating transcription factor binding site information with gene expression datasets

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007.

Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors

OvMark: a user-friendly system for the identification of prognostic biomarkers in publically available ovarian cancer gene expression datasets.

Overexpression of the microRNA miR-433 promotes resistance to paclitaxel through the induction of cellular senescence in ovarian cancer cells.

Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells

Repuncturing the renal biopsy: strategies for molecular diagnosis in nephrology.

Sustained Expression of Steroid Receptor Coactivator SRC-2/TIF-2 is Associated with Better Prognosis in Malignant Pleural Mesothelioma ⬇️

Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer

TGFβ and CCN2/CTGF mediate actin related gene expression by differential E2F1/CREB activation

The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer

The prognostic utility of the transcription factor SRF in docetaxel-resistant prostate cancer: in-vitro discovery and in-vivo validation

Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer

Tyrosine kinase inhibitors as modulators of trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity in breast cancer cell lines.

Vitamin D receptor as a target for breast cancer therapy

miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro